Announcement
Lorenzo Cazzullo, U. Wald, H.-P. Hebestreit, Shalom Michowitz, Giancarlo Poiana, Stefano Biagioni, Eugenio Caputi, L. Andreussi, F Lesoin, G. Scarsella, Roger Godbout(Université de Montréal), Maria Pia Amato(University of Florence), G Porro, K. Schwechheimer, Angelo Ghezzi(Associazione Italiana Sclerosi Multipla), M Jomin, Rolando Giannaula, Antonia Cama, Guillermo Paradiso, Laura Vallee, Milisav Nikolić, Vladimir Kostić(University of Belgrade), Shu‐ichi Ikeda(Kobe University), H.-E. Nau, Ljiliana Bumbaširević-Beslać, V. Reinhardt, Estela Lehkuniec, Eiji Tanaka(Shinshu University), I. Steiner, Masanobu Yazawa, Federico Micheli, Pasquale Carboni, P. Berlit, Mafumi Owa, H. Howald, H. Wiedemayer, Nadežda Čovičković-Šternić, M.A. Bédard, P. Dhellemmes, J.P. Nuyts, D. Gottlieb, G. Von Muralt, Bogdan M. Djuričić, B. B. Mršulja, Masahide Watanabe, J. Montplaisir(Hôpital du Sacré-Cœur de Montréal), Seiichi Haruta, Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Nobuo Yanagisawa, Domenico Caputo(Don Carlo Gnocchi Foundation)
Cited by 0
Related Papers
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
|Hepatology|1990|1.2k
Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria
|Movement Disorders|1997|936
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624